columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiset aineet - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
lenalidomide sandoz 2.5 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 2.5 mg - lenalidomidi
lenalidomide sandoz 5 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 5 mg - lenalidomidi
lenalidomide sandoz 7.5 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 7.5 mg - lenalidomidi
lenalidomide sandoz 10 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 10 mg - lenalidomidi
lenalidomide sandoz 15 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 15 mg - lenalidomidi
lenalidomide sandoz 20 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 20 mg - lenalidomidi
lenalidomide sandoz 25 mg kapseli, kova
sandoz a/s - lenalidomide - kapseli, kova - 25 mg - lenalidomidi
lenalidomid avansor 2.5 mg kapseli, kova
avansor pharma oy - lenalidomide - kapseli, kova - 2.5 mg - lenalidomidi
lenalidomid avansor 5 mg kapseli, kova
avansor pharma oy - lenalidomide - kapseli, kova - 5 mg - lenalidomidi